PolyPill for cardiovascular diseases

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 2 registered trials.

Also followed for narrower conditions: Heart Diseases, Hypertension, Non-ST Elevated Myocardial Infarction, ST Elevation Myocardial Infarction

Why this status

  1. 20 Dec 2015: Trial started, NCT03459560
  2. 9 Mar 2018: Trial registered, NCT03459560

The trials

NCT01245608: Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables.

State
Completed
Phase
Phase 3
People
2,400 taking part
Started
Oct 2011
Primary completion
Jan 2018
Arms
Polypill
Results
None posted
  1. 22 Nov 2010: Trial registered

NCT03459560: Prevention of Cardiovascular Disease With Polypill Among Pars Cohort Participants

State
State not given
Phase
Phase 3
People
4,415 taking part
Started
20 Dec 2015
Primary completion
20 Mar 2022
Arms
PolyPill
Results
None posted
  1. 20 Dec 2015: Trial started
  2. 9 Mar 2018: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.